BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2844657)

  • 1. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
    Parry NR; Syred A; Rowlands DJ; Brown F
    Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodies.
    Borca MV; Garmendia AE; Baxt B; Moore DM; Srikumaran S; Morgan DO
    Immunology; 1993 Jul; 79(3):368-74. PubMed ID: 8406565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies.
    Flynn JN; Harkiss GD; Doel T; DiMarchi R
    Immunology; 1990 Jan; 69(1):1-7. PubMed ID: 1690176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to uncoupled peptides of foot-and-mouth disease virus.
    Francis MJ; Fry CM; Rowlands DJ; Bittle JL; Houghten RA; Lerner RA; Brown F
    Immunology; 1987 May; 61(1):1-6. PubMed ID: 3034769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A].
    Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN
    Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease.
    Steward MW; Stanley CM; Dimarchi R; Mulcahy G; Doel TR
    Immunology; 1991 Jan; 72(1):99-103. PubMed ID: 1847695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
    Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
    Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigenic structure of foot-and-mouth virus. IV. Synthesis and immunogenic properties of new fragments of the VP1 protein of food-and-mouth virus strain A22].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Lugovskoĭ AA; Driagalin NN; Ivaniushchenkov VN
    Bioorg Khim; 1989 Sep; 15(9):1193-205. PubMed ID: 2556150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals.
    Winther MD; Allen G; Bomford RH; Brown F
    J Immunol; 1986 Mar; 136(5):1835-40. PubMed ID: 3005401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes.
    Garmendia AE; Borca MV; Morgan DO; Baxt B
    J Immunol; 1989 Nov; 143(9):3015-9. PubMed ID: 2553817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
    Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
    Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.
    Francis MJ; Hastings GZ; Clarke BE; Brown AL; Beddell CR; Rowlands DJ; Brown F
    Immunology; 1990 Feb; 69(2):171-6. PubMed ID: 2155177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G
    Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren].
    Liebermann H; Reimann I; Bartels T; Nöckler A; Thalmann G; Furkert J; Dölling R
    Arch Exp Veterinarmed; 1990; 44(2):189-97. PubMed ID: 1696803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.
    Francis MJ; Hastings GZ; Syred AD; McGinn B; Brown F; Rowlands DJ
    Nature; 1987 Nov 12-18; 330(6144):168-70. PubMed ID: 2444892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
    Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
    Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.